The new SAFC biopharma manufacturing facility in St. Louis enables the production of plant- and animal-based proteins for drug development. The $18 million facility was created by retrofitting an existing building and contains some of the largest extraction and purification suites. It addresses customer concerns about cross-contamination by having completely separate operations for plant and animal production. The flexible facility can support multiple custom projects simultaneously while meeting strict quality standards on time and under budget.